Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.62
-0.2550-0.88%
Post-market: 28.740.1250+0.44%19:55 EDT
Volume:3.47M
Turnover:98.73M
Market Cap:3.21B
PE:-24.81
High:29.01
Open:28.91
Low:27.69
Close:28.87
Loading ...

Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential

TIPRANKS
·
26 Mar

Viking Therapeutics Inc: Expects to Report Data From Study in Second Half of 2025.

THOMSON REUTERS
·
26 Mar

Viking Therapeutics Announces Completion of Enrollment in Phase 2 Venture-Oral Dosing Trial of Vk2735 Tablet Formulation in Patients With Obesity

THOMSON REUTERS
·
26 Mar

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

PR Newswire
·
26 Mar

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Zacks
·
25 Mar

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

Simply Wall St.
·
18 Mar

What might happen next after the S&P 500's correction?

Dow Jones
·
14 Mar

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Quartz
·
14 Mar

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Zacks
·
14 Mar

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks
·
13 Mar

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Zacks
·
13 Mar

B. Riley sees two key positives in Viking manufacturing agreement

TIPRANKS
·
11 Mar

Viking Therapeutics closer to bringing its Ozempic competitor to market

Quartz
·
11 Mar

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Viking supply pact may hurt takeover prospects, says William Blair

TIPRANKS
·
11 Mar

Cordenpharma, Viking Therapeutics form long-term partnership to provide key materials to make injectable and oral medications

Reuters
·
11 Mar

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Blockhead
·
11 Mar

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

Zacks
·
11 Mar

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Zacks
·
11 Mar

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

MT Newswires Live
·
11 Mar